Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) has announced an increase to its non-brokered private placement offering, raising the maximum proceeds from $420,000 to up to $500,000.01. The medical device developer is now proposing to sell up to 16,666,667 common shares at $0.03 per share, citing investor interest that exceeded the originally announced offering size. The expansion signals continued financing activity at the company as it works to fund manufacturing, marketing, and working capital needs.

Key Points

  • Therma Bright Inc. (TSXV: THRM | OTCQB: TBRIF | FSE: JNX0) is a Toronto-based medical device developer and investment partner
  • The company has increased its non-brokered private placement from up to $420,000 to up to $500,000.01, offering up to 16,666,667 common shares at $0.03 per share
  • Proceeds are earmarked across five categories, including $120,000 for a manufacturing deposit and $248,000 for outstanding debt and general working capital
  • Investors may watch for TSXV regulatory approval and confirmation of closing, as the offering remains subject to exchange approval

Therma Bright Upsizes Offering After Strong Investor Interest

The company announced on November 12, 2026 that it is increasing the size of a non-brokered private placement first disclosed on October 23, 2026. The updated offering proposes the sale of up to 16,666,667 common shares at $0.03 per share, generating total proceeds of up to $500,000.01. The release states the company is relying on a minimum pricing exception under TSX Venture Exchange policies to issue securities below the standard $0.05 minimum per listed security. All securities issued will be subject to a hold period expiring four months and one day from their date of issuance.

Planned Allocation of Private Placement Proceeds

Therma Bright has outlined five specific uses for the proceeds. The largest allocation — $248,000 — is designated for outstanding debt repayment and general working capital. A further $120,000 is earmarked as an initial deposit related to product manufacturing. The company also plans to spend $50,000 on a consumer marketing analysis, up to $42,000 on investor relations activities, and $40,000 to reimburse management expenses and partially address accrued salary obligations. The company did not disclose further details regarding the specific products involved in the manufacturing deposit.

Director and Officer Participation and Related-Party Considerations

The announcement states that directors and officers may participate in the offering. Such participation would constitute a related-party transaction under Multilateral Instrument 61-101. However, the company expects this participation to qualify for an exemption from formal valuation and minority shareholder approval requirements, as the value of securities to be acquired by insiders is not expected to exceed 25% of the company's market capitalisation. Finders' fees may also be paid to eligible finders, subject to applicable securities laws and TSXV policy compliance.

Regulatory Approvals and Completion Conditions

Completion of the offering remains subject to all necessary regulatory approvals, including approval from the TSX Venture Exchange. The securities have not been registered under the United States Securities Act of 1933 and may not be offered or sold to U.S. persons absent registration or an applicable exemption. The immediate share price impact was not clear from available public information.